bucladesine has been researched along with Cardiac Failure in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (50.00) | 18.7374 |
| 1990's | 7 (29.17) | 18.2507 |
| 2000's | 5 (20.83) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Funayama, H; Ishikawa, SE; Kasono, K; Saito, T | 1 |
| He, JQ; Kamp, TJ | 1 |
| Chen, X; Furukawa, S; Goldman, B; Houser, SR; Margulies, KB; Piacentino, V | 1 |
| Berretta, RM; Chen, X; Harris, DM; Houser, SR; Margulies, KB; Piacentino, V; Zhang, X | 1 |
| Hashimoto, H; Niizoe, K; Ogawa, K; Okumura, K | 1 |
| Emoto, J; Matoba, M; Matsui, S; Murakami, E; Takekoshi, N | 2 |
| Buser, PT; Jasmin, G; Parmley, WW; Wikman-Coffelt, J; Wu, SY | 1 |
| Cove, CJ; Hood, WB; Stuver, TP | 1 |
| Arentzen, CE; Backer, CL; Koumi, S; Sato, R | 1 |
| De Mello, WC | 1 |
| Bartel, S; Eschenhagen, T; Haverich, A; Hirt, S; Karczewski, P; Krause, EG; Neumann, J; Schmitz, W; Scholz, H; Stein, B; Thoenes, M | 1 |
| Barrère-Lemaire, S; Leclercq, F; Nargeot, J; Piot, C; Richard, S | 1 |
| Del Monte, F; Harding, SE; Jones, SM; Poole-Wilson, PA; Vescovo, G | 1 |
| Asanoi, H; Fujita, M; Miyagi, Y; Nakajima, H; Sasayama, S | 1 |
| Fujita, M; Miyagi, Y; Nakajima, H; Sasayama, S | 1 |
| Matoba, M | 1 |
| Fukuzaki, H; Nakanishi, M; Yokota, Y | 1 |
| Hoshino, Y | 1 |
| Imura, K; Ito, T; Ogawa, K; Satake, T | 1 |
| Miyazaki, M; Sugai, K; Sugai, Y | 1 |
| Goto, A; Ishiguro, M; Miyake, H; Mizutani, T; Morita, N; Ohashi, H; Sugishita, N; Watanabe, S; Yasue, T | 1 |
| Gertler, MM; Guthrie, RG; Leetma, HE; Saluste, E; Starr, T | 1 |
1 trial(s) available for bucladesine and Cardiac Failure
| Article | Year |
|---|---|
Comparative hemodynamic effects of intravenous dobutamine and dibutyryl cyclic AMP, a new inotropic agent, in severe congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Bucladesine; Cardiac Output; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Vascular Resistance | 1990 |
23 other study(ies) available for bucladesine and Cardiac Failure
| Article | Year |
|---|---|
Pathophysiological role of aquaporin-2 in impaired water excretion.
Topics: Animals; Aquaporin 2; Arginine Vasopressin; Bucladesine; Deamino Arginine Vasopressin; Disease Models, Animal; Diuresis; Gene Expression Regulation; Genes, Reporter; Heart Failure; Inappropriate ADH Syndrome; Kidney; Luciferases; Promoter Regions, Genetic; Rats; RNA, Messenger; Water-Electrolyte Imbalance | 2008 |
L-type Ca2+ channels gaining respect in heart failure.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic beta-Agonists; Bucladesine; Calcium Channel Agonists; Calcium Channels, L-Type; Heart Failure; Heart Ventricles; Humans; Isoproterenol; Membrane Potentials | 2002 |
L-type Ca2+ channel density and regulation are altered in failing human ventricular myocytes and recover after support with mechanical assist devices.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic beta-Agonists; Bucladesine; Calcium Channel Agonists; Calcium Channels, L-Type; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Heart Failure; Heart Ventricles; Heart-Assist Devices; Humans; Isoproterenol; Membrane Potentials; Middle Aged; Okadaic Acid; Phosphoprotein Phosphatases; Phosphorylation; Protein Phosphatase 2 | 2002 |
Reduced effects of BAY K 8644 on L-type Ca2+ current in failing human cardiac myocytes are related to abnormal adrenergic regulation.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Adrenergic beta-Agonists; Bucladesine; Calcium Channel Agonists; Calcium Channels, L-Type; Cardiotonic Agents; Catecholamines; Drug Resistance; Heart Failure; Heart Ventricles; Heart-Assist Devices; Humans; Isoproterenol; Membrane Potentials; Myocardial Contraction; Myocytes, Cardiac; Phosphorylation | 2008 |
Effects of dibutyryl cyclic AMP on patients with severe heart failure.
Topics: Adult; Blood Glucose; Bucladesine; Fatty Acids, Nonesterified; Heart Failure; Heart Rate; Humans; Infusions, Parenteral; Insulin; Male; Middle Aged; Pulmonary Wedge Pressure; Vascular Resistance | 1982 |
Hemodynamic effects of dibutyryl cyclic AMP in congestive heart failure.
Topics: Aged; Blood Pressure; Bucladesine; Cardiac Output; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Stroke Volume; Vascular Resistance | 1983 |
Distinct modulation of myocardial performance, energy metabolism, and [Ca2+]i transients by positive inotropic drugs in normal and severely failing hamster hearts.
Topics: Amrinone; Animals; Blood Pressure; Bucladesine; Calcium; Cardiomyopathies; Cardiotonic Agents; Cricetinae; Digoxin; Disease Models, Animal; Dobutamine; Energy Metabolism; Heart Failure; Isoproterenol; Magnetic Resonance Spectroscopy; Mesocricetus; Myocardial Contraction; Oxygen Consumption; Phosphates; Phosphorylation | 1995 |
Mechanical abnormalities in the rat ischemic heart failure model which lie downstream to cAMP production.
Topics: Animals; Bucladesine; Cyclic AMP; Disease Models, Animal; Heart Failure; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Papillary Muscles; Rats; Rats, Sprague-Dawley | 1994 |
beta-Adrenergic modulation of the inwardly rectifying potassium channel in isolated human ventricular myocytes. Alteration in channel response to beta-adrenergic stimulation in failing human hearts.
Topics: Adrenergic beta-Agonists; Adult; Alkaline Phosphatase; Analysis of Variance; Barium; Bucladesine; Cardiomyopathy, Dilated; Cells, Cultured; Colforsin; Coronary Disease; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Female; Heart; Heart Failure; Heart Ventricles; Humans; Isoproterenol; Kinetics; Male; Membrane Potentials; Middle Aged; Myocardium; Patch-Clamp Techniques; Potassium Channels; Potassium Channels, Inwardly Rectifying; Propranolol | 1995 |
Atrial natriuretic factor reduces cell coupling in the failing heart, an effect mediated by cyclic GMP.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Atrial Natriuretic Factor; Bucladesine; Cardiomyopathies; Cell Communication; Cricetinae; Cyclic GMP; Electrophysiology; Gap Junctions; Heart Failure; Heart Ventricles; Male; Mesocricetus; Phosphodiesterase Inhibitors; Purinones; Receptors, Atrial Natriuretic Factor | 1998 |
Dissociation of the effects of forskolin and dibutyryl cAMP on force of contraction and phospholamban phosphorylation in human heart failure.
Topics: Adolescent; Adult; Aged; Bucladesine; Calcium-Binding Proteins; Cardiotonic Agents; Colforsin; Female; Heart Failure; Humans; In Vitro Techniques; Male; Middle Aged; Myocardial Contraction; Phosphorylation | 1999 |
Facilitation of L-type calcium currents by diastolic depolarization in cardiac cells: impairment in heart failure.
Topics: Adrenergic beta-Agonists; Adult; Aged; Animals; Barium; Bucladesine; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclic AMP-Dependent Protein Kinases; Diastole; Electric Stimulation; Heart Atria; Heart Failure; Heart Ventricles; Humans; Isoproterenol; Membrane Potentials; Middle Aged; Myocardium; Patch-Clamp Techniques; Rats; Rats, Inbred WKY; Ryanodine; Sarcolemma; Serotonin | 2000 |
Reduced contractile responses to forskolin and a cyclic AMP analogue in myocytes from failing human ventricle.
Topics: Adult; Aging; Bucladesine; Calcium; Colforsin; Diuretics; Female; Heart Failure; Heart Ventricles; Humans; In Vitro Techniques; Isoproterenol; Male; Middle Aged; Myocardial Contraction | 1992 |
Effects of DBcAMP on exercise capacity in patients with and without chronic heart failure.
Topics: Adolescent; Adult; Bucladesine; Chronic Disease; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Oxygen Consumption; Physical Exertion | 1989 |
[Choice for the treatment of congestive heart failure].
Topics: Administration, Oral; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Blood Flow Velocity; Bucladesine; Cardiac Output; Cardiotonic Agents; Echocardiography, Doppler; Electrocardiography, Ambulatory; Heart Failure; Heart Rate; Humans; Physical Endurance; Pulmonary Veins; Vasodilator Agents | 1989 |
Efficacy of dibutyryl cyclic AMP in heart failure unresponsive to catecholamines.
Topics: Adolescent; Adult; Aged; Bucladesine; Cardiomyopathy, Dilated; Catecholamines; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1987 |
[The sympathetic nervous activity and beta-adrenergic receptor function in congestive heart failure].
Topics: Bucladesine; Dobutamine; Heart Failure; Humans; Lymphocytes; Norepinephrine; Receptors, Adrenergic, beta; Sympathetic Nervous System | 1987 |
Cardiovascular effects of dibutyryl cyclic AMP in patients with congestive heart failure--comparison with dobutamine and captopril.
Topics: Aged; Blood Pressure; Bucladesine; Captopril; Cardiac Output; Dobutamine; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Vascular Resistance | 1988 |
Acute effects of dibutyryl cyclic AMP on renal circulation in congestive heart failure.
Topics: Bucladesine; Dopamine; Epinephrine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Renal Circulation | 1988 |
Hemodynamic effects of BTB-cyclic AMP in anesthetized dogs.
Topics: Animals; Blood Pressure; Bucladesine; Cyclic AMP; Dogs; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Male; Myocardial Contraction; Shock, Cardiogenic; Stroke Volume; Vascular Resistance | 1986 |
The control of hypertension with dibutyryl cyclic AMP.
Topics: Aged; Anesthesia, General; Antihypertensive Agents; Blood Pressure; Bucladesine; Cardiac Output; Drug Evaluation; Female; Heart Failure; Heart Rate; Humans; Hypertension; Infusions, Intravenous; Kidney Diseases; Male; Middle Aged; Research Design; Stroke Volume; Urine; Vascular Resistance | 1987 |
[Monitoring of LV function in coronary care unit--evaluation of the effect of a vasodilator by the nuclear cardiac probe].
Topics: Bucladesine; Cardiac Output; Coronary Care Units; Female; Heart Failure; Heart Function Tests; Heart Ventricles; Humans; Male; Microcomputers; Middle Aged; Monitoring, Physiologic; Scintillation Counting; Stroke Volume | 1987 |
The use of cyclic AMP in ischemic vascular disorders.
Topics: Aged; Blood Glucose; Blood Platelets; Bucladesine; Coronary Disease; Cyclic AMP; Fatty Acids, Nonesterified; Female; Heart Failure; Humans; Insulin; Lactates | 1973 |